pmid	doi	year	title	Hugo_Symbol
32782434	10.1186/s12935-020-01457-8	2022	Evaluation of the upregulation and surface expression of hypoxanthine guanine phosphoribosyltransferase in acute lymphoblastic leukemia and Burkitt's B cell lymphoma.	MSH6
33811277	10.1007/s10689-021-00244-2	2022	Constitutional 2p16.3 deletion including MSH6 and FBXO11 in a boy with developmental delay and diffuse large B-cell lymphoma.	MSH6
33928678	10.1111/den.14004	2022	Clinicopathological features and risk factors for developing colorectal neoplasia in Hodgkin's lymphoma survivors.	MSH6
34538134	10.1177/03009858211022704	2022	Mismatch repair deficiency in canine neoplasms.	MSH6
34787334	10.1111/pde.14861	2022	Eruptive nevi in a patient with constitutional mismatch repair deficiency (CMMRD).	MSH6
35227120	10.1177/10935266221075605	2022	Diffuse Large B-Cell Lymphoma, Epstein-Barr Virus -Positive Kappa Monotypic Plasma Cell Proliferation and Invasive Carcinoma, Developing in a Child With Defective Mismatch Repair.	MSH6
35359413	10.3389/fonc.2022.817635	2022	Analysis of Genetic Alterations in Ocular Adnexal Mucosa-Associated Lymphoid Tissue Lymphoma With Whole-Exome Sequencing.	MSH6
35812033	10.1136/flgastro-2022-102123	2022	Diagnosis and management of Lynch syndrome.	MSH6
36097110	10.1007/s11033-022-07761-y	2022	Looking beyond the cytogenetics in haematological malignancies: decoding the role of tandem repeats in DNA repair genes.	MSH6
32022486	10.1002/cam4.2870	2021	Microsatellite instability and its associations with the clinicopathologic characteristics of diffuse large B-cell lymphoma.	MSH6
32866816	10.1016/j.jns.2020.117102	2021	Preconditioning with INC280 and LDK378 drugs sensitizes MGMT-unmethylated glioblastoma to temozolomide: Pre-clinical assessment.	MSH6
34086170	10.1007/s10549-021-06258-9	2021	Double heterozygotes of BRCA1/BRCA2 and mismatch repair gene pathogenic variants: case series and clinical implications.	MSH6
34425783	10.1186/s12876-021-01902-6	2021	Intensive surveillance endoscopy for multiple gastrointestinal tumors in a patient with constitutional mismatch repair deficiency: case report.	MSH6
30147880	10.1002/ccr3.1564	2020	Rare compound heterozygous mutations in gene <i>MSH6</i> cause constitutive mismatch repair deficiency syndrome.	MSH6
30456894	10.1002/jcp.27620	2020	Inhibitory effect of MSH6 gene silencing in combination with cisplatin on cell proliferation of human osteosarcoma cell line MG63.	MSH6
31697823	10.1182/blood.2019002220	2020	Therapy-induced mutations drive the genomic landscape of relapsed acute lymphoblastic leukemia.	MSH6
33143351	10.3390/pathogens9110909	2020	Bovine Leukemia Virus Infection Affects Host Gene Expression Associated with DNA Mismatch Repair.	MSH6
29449434	10.3324/haematol.2017.176362	2019	MSH6 haploinsufficiency at relapse contributes to the development of thiopurine resistance in pediatric B-lymphoblastic leukemia.	MSH6
29904176	10.1038/s41431-018-0197-0	2019	Cancer prevention by aspirin in children with Constitutional Mismatch Repair Deficiency (CMMRD).	MSH6
30551794	10.1016/j.bulcan.2018.10.008	2019	[Constitutional MMR deficiency: Genetic bases and clinical implications].	MSH6
30734108	10.1007/s00428-019-02528-6	2019	Comprehensive analysis of PD-L1 expression, HER2 amplification, ALK/EML4 fusion, and mismatch repair deficiency as putative predictive and prognostic factors in ovarian carcinoma.	MSH6
28142295	10.1080/10428194.2017.1283029	2018	Identification of a tumor suppressor network in T-cell leukemia.	MSH6
28465297	10.1158/1541-7786.MCR-16-0305	2018	Comprehensive Transcriptome and Mutational Profiling of Endemic Burkitt Lymphoma Reveals EBV Type-Specific Differences.	MSH6
28728506	10.1080/10245332.2017.1354428	2018	Microsatellite Instability and Promoter Hypermethylation of DNA repair genes in Hematologic Malignancies: a forthcoming direction toward diagnostics.	MSH6
28923119	10.1186/s13000-017-0645-0	2018	ALK-positive gastric inflammatory myofibroblastic tumor in an adult with familial adenomatous polyposis and diffuse fundic polyposis.	MSH6
29439113	10.1136/gutjnl-2016-312608	2018	Double somatic mutations in mismatch repair genes are frequent in colorectal cancer after Hodgkin's lymphoma treatment.	MSH6
27017609	10.1007/s10689-016-9894-4	2017	MSI detection and its pitfalls in CMMRD syndrome in a family with a bi-allelic MLH1 mutation.	MSH6
28157215	10.1038/bcj.2017.3	2017	Identification of a genetically defined ultra-high-risk group in relapsed pediatric T-lymphoblastic leukemia.	MSH6
28562508	10.1097/MPH.0000000000000863	2017	Biallelic PMS2 Mutation and Heterozygous DICER1 Mutation Presenting as Constitutional Mismatch Repair Deficiency With Corpus Callosum Agenesis: Case Report and Review of Literature.	MSH6
28981733	10.1093/jjco/hyx098	2017	Prognostic factors for primary central nervous system lymphomas treated with high-dose methotrexate-based chemo-radiotherapy.	MSH6
25978431	10.1038/bcj.2015.35	2016	NPM-ALK mediates phosphorylation of MSH2 at tyrosine 238, creating a functional deficiency in MSH2 and the loss of mismatch repair.	MSH6
26004186	10.1016/j.celrep.2015.04.052	2016	The CREB Coactivator CRTC2 Is a Lymphoma Tumor Suppressor that Preserves Genome Integrity through Transcription of DNA Mismatch Repair Genes.	MSH6
26318770	10.1136/jmedgenet-2015-103299	2016	Constitutional mismatch repair deficiency syndrome: clinical description in a French cohort.	MSH6
26498208	10.1016/j.mrfmmm.2015.10.001	2016	Microsatellite instability detected in tumor-related genes in C57BL/6J mice with thymic lymphoma induced by N-methyl-N-nitrosourea.	MSH6
26544533	10.1002/pbc.25818	2016	Constitutional Mismatch Repair Deficiency in Israel: High Proportion of Founder Mutations in MMR Genes and Consanguinity.	MSH6
26558945	10.1615/critreveukaryotgeneexpr.2015013893	2016	Genes Associated with Human Cancers: Their Expressions, Features, Functions, and Significance.	MSH6
26599546	10.1371/journal.pone.0139663	2016	Genomic Landscape of Primary Mediastinal B-Cell Lymphoma Cell Lines.	MSH6
26743104	10.1016/j.ejmg.2015.12.014	2016	Acute lymphoblastic leukemia and lymphoma in the context of constitutional mismatch repair deficiency syndrome.	MSH6
24068316	10.1007/s10689-013-9676-1	2015	Diversity of the clinical presentation of the MMR gene biallelic mutations.	MSH6
24662245	10.1038/ncomms4469	2015	Mutations in epigenetic regulators including SETD2 are gained during relapse in paediatric acute lymphoblastic leukaemia.	MSH6
25431869	10.1055/s-0034-1389905	2015	Constitutional mismatch repair-deficiency and whole-exome sequencing as the means of the rapid detection of the causative MSH6 defect.	MSH6
22916837	10.3109/10428194.2012.723211	2013	Analysis of microsatellite instability in gastric mucosa-associated lymphoid tissue lymphoma.	MSH6
23066952	10.3109/10428194.2012.739687	2013	Mutation mismatch repair gene deletions in diffuse large B-cell lymphoma.	MSH6
23960188	10.1084/jem.20122842	2013	DNA repair genes are selectively mutated in diffuse large B cell lymphomas.	MSH6
21674763	10.1002/pbc.23217	2012	High-grade brain tumors in siblings with biallelic MSH6 mutations.	MSH6
22000951	10.1016/j.jcpa.2011.08.009	2012	Widespread mismatch repair expression in feline small intestinal lymphomas.	MSH6
22083360	10.3791/3573	2012	Assessing somatic hypermutation in Ramos B cells after overexpression or knockdown of specific genes.	MSH6
22493294	10.1182/blood-2011-10-386862	2012	Phenotype diversity in type 1 Gaucher disease: discovering the genetic basis of Gaucher disease/hematologic malignancy phenotype by individual genome analysis.	MSH6
22920205		2012	[Constitutional mismatch repair-deficiency syndrome (CMMR-D) - a case report of a family with biallelic MSH6 mutation].	MSH6
20015892	10.3324/haematol.2009.015503	2011	Constitutional mismatch repair deficiency and childhood leukemia/lymphoma--report on a novel biallelic MSH6 mutation.	MSH6
20846793	10.1016/j.prp.2010.07.007	2011	Concomitant adenocarcinoma and colonic non-Hodgkin's lymphoma in a patient with ulcerative colitis: a case report and molecular analysis.	MSH6
20934970	10.2353/ajpath.2010.100234	2011	Msh6 protects mature B cells from lymphoma by preserving genomic stability.	MSH6
21703420	10.1016/j.ajpath.2011.03.045	2011	Fusion tyrosine kinase NPM-ALK Deregulates MSH2 and suppresses DNA mismatch repair function novel insights into a potent oncoprotein.	MSH6
22164924		2011	[Management of hereditary non-polyposis syndrome (Lynch syndrome)].	MSH6
20305618	10.1038/modpathol.2010.41	2010	Endometrial and ovarian carcinomas with undifferentiated components: clinically aggressive and frequently underrecognized neoplasms.	MSH6
20567595	10.1371/journal.pone.0011182	2010	MSH2/MSH6 complex promotes error-free repair of AID-induced dU:G mispairs as well as error-prone hypermutation of A:T sites.	MSH6
19194194	10.1097/MPH.0b013e31818b3774	2009	Compound heterozygosity for MSH6 mutations in a pediatric lymphoma patient.	MSH6
19551857	10.1002/ijc.24681	2009	The mechanisms underlying MMR deficiency in immunodeficiency-related non-Hodgkin lymphomas are different from those in other sporadic microsatellite instable neoplasms.	MSH6
17601929	10.1136/jmg.2007.048942	2008	Familial T-cell non-Hodgkin lymphoma caused by biallelic MSH2 mutations.	MSH6
17851451	10.1038/sj.ejhg.5201923	2008	Homozygous PMS2 germline mutations in two families with early-onset haematological malignancy, brain tumours, HNPCC-associated tumours, and signs of neurofibromatosis type 1.	MSH6
18593904	10.1158/0008-5472.CAN-08-0019	2008	Zebrafish with mutations in mismatch repair genes develop neurofibromas and other tumors.	MSH6
18768390	10.1182/blood-2008-06-165027	2008	Genome-wide copy number profiling reveals molecular evolution from diagnosis to relapse in childhood acute lymphoblastic leukemia.	MSH6
17240451	10.1016/j.molimm.2006.12.006	2007	Known components of the immunoglobulin A:T mutational machinery are intact in Burkitt lymphoma cell lines with G:C bias.	MSH6
17440981	10.1002/cncr.22697	2007	Biallelic germline mutations of mismatch-repair genes: a possible cause for multiple pediatric malignancies.	MSH6
16283678	10.1002/ajmg.a.30998	2006	Neurofibromatosis von Recklinghausen type I phenotype and early onset of cancers in siblings compound heterozygous for mutations in MSH6.	MSH6
15805259	10.1158/0008-5472.CAN-04-3158	2005	A lack of DNA mismatch repair on an athymic murine background predisposes to hematologic malignancy.	MSH6
16000562	10.1158/1078-0432.CCR-04-2025	2005	A homozygous mutation in MSH6 causes Turcot syndrome.	MSH6
14762794	10.1053/j.gastro.2003.11.008	2004	Gastrointestinal cancers and neurofibromatosis type 1 features in children with a germline homozygous MLH1 mutation.	MSH6
12400605	10.1080/1042819021000002956	2003	Analysis of mismatch repair defects in the familial occurrence of lymphoma and colorectal cancer.	MSH6
12538346	10.1093/carcin/24.1.31	2003	Assessment of mismatch repair function in leukaemic cell lines and blasts from children with acute lymphoblastic leukaemia.	MSH6
10498615		1999	Mutator phenotype in human hematopoietic neoplasms and its association with deletions disabling DNA repair genes and bcl-2 rearrangements.	MSH6
10500837	10.1007/978-1-4615-4811-9_64	1999	Expression of DNA mismatch repair proteins in acute lymphoblastic leukaemia and normal bone marrow.	MSH6
10545954	10.1038/15544	1999	HNPCC-like cancer predisposition in mice through simultaneous loss of Msh3 and Msh6 mismatch-repair protein functions.	MSH6
9510473	10.1111/j.1349-7006.1998.tb00476.x	1998	Frameshift mutations of the hMSH6 gene in human leukemia cell lines.	MSH6
9390556	10.1016/s0092-8674(00)80433-x	1997	Mutation in the mismatch repair gene Msh6 causes cancer susceptibility.	MSH6
